Drug
Detralex
Detralex is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
unknown
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
NCT05113420
completed
Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease
NCT03743311
completedphase_4
Study of Antiinflammatory Effects of Detralex (Daflon)
NCT01654016
Clinical Trials (3)
Showing 3 of 3 trials
NCT05113420
The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
NCT03743311
Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease
NCT01654016Phase 4
Study of Antiinflammatory Effects of Detralex (Daflon)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3